Skye Bioscience, Inc. (SKYE) analyst actions
Rating and price-target actions on SKYE in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SKYE overview →
2 measured SKYE analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Skye Bioscience, Inc. (SKYE) And Encourages Stockholders to Reach Out | Press release | -1.98% | -3.67% | |
| Skye Bioscience Comments on Monlunabant Phase 2 Top-line Data and Reiterates Confidence in Nimacimab Clinical Development Plan | Press release | +0.91% | +5.44% |
Keep exploring
More SKYE: earnings → · SEC filings → · SKYE overview →